May 25, 2022CorporateTerumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022CorporateTerumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022CorporateTerumo Announces Change in Indication for Dexcom G6 CGM System in Japan Adjunctive use of Blood Glucose Meter Principally Not Required
Refining Searches 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Corporate Financial December 25, 2014 Corporate Terumo Commences Sales of Tercross® PTA Balloon Catheters in Europe Designed for a Wide Range of Treatments for Small Peripheral Blood Vessels Including Ones Below The Knee December 15, 2014 Corporate Government of Ghana Endorses Collaboration to Combat Ebola Epidemic Page Content AABB, Global Blood Fund and Terumo BCT commit resources to Ghanaian Ebola Readiness and Resilience Initiative December 04, 2014 Corporate Terumo receives CE Mark approval for the line extension on Drug-eluting Stent, Ultimaster® to advance the treatment of coronary artery disease October 31, 2014 Corporate Terumo Announces its Application for the Manufacture and Sales Approval of its Skeletal Myoblast Sheets - To Aim for the World's First Cardiac Regenerative Therapy (PDF 217.6 KB) October 23, 2014 Corporate Terumo transforms product portfolio of Hospital and Laboratory Business in Europe (PDF 177.35 KB) September 23, 2014 Corporate Terumo Cardiovascular Group to Distribute Nonin Medical’s SenSmart™ Model X-100 Universal Oximetry System in U.S. Cardiovascular Hospitals August 08, 2014 Corporate Announcement of a New Corporate Logo Mark August 06, 2014 Financial Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 56.35 KB) May 20, 2014 Corporate Terumo BCT Enters Agreement with Kaneka CorporationMulti-year collaboration agreement for the combined use of therapeutic apheresis and columns for LDL reduction May 15, 2014 Corporate Terumo® Launches Expanded GLIDEWAY™ Access Sheath Portfolio With A New Product For Minimally Invasive Urologic Procedures New GLIDEWAY™ Ureteral Access Sheath Offers Advanced Features Designed to Minimize Trauma May 08, 2014 Financial Notice Concerning the Renewal of a Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures) (PDF 129.84 KB) April 24, 2014 Corporate New Candidate for Independent Director April 24, 2014 Corporate Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA) April 02, 2014 Corporate Terumo Expands Sales Collaboration in Japan with Biosensors for Nobori® DES and Extends Licensing Agreement to Sell the Product Overseas March 27, 2014 Corporate Election of New Board Members March 25, 2014 Corporate Terumo BCT Becomes Therakos Inc. Distributor in Latin America Multi-year agreement enables Terumo BCT to provide Therakos products in several Latin American countries March 14, 2014 Corporate Terumo Announces Exclusive Acquisition Right Agreement with French Bioresorbable Scaffold Company, "ART" February 12, 2014 Corporate Terumo Wins Pharmapack 2014 Award For Nanopass® 34 Pen-Needle In The Category "Quality Of Life" February 03, 2014 Corporate Terumo Receives CE Mark for Its New Drug-eluting Stent, Ultimaster™ January 28, 2014 Corporate Nonin Medical Announces U.K. and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart™ Universal Oximetry System January 28, 2014 Corporate U.S. Food and Drug Administration Clears Granulocyte Collection Procedure on the Spectra Optia Apheresis System Granulocyte, or polymorphonuclear [PMN] cell, collections on the next-generation therapeutic apheresis platform to optimize cellular collections and supplement current protocol offering Pagination Previous page ‹ Current page1 Next page ›
December 25, 2014 Corporate Terumo Commences Sales of Tercross® PTA Balloon Catheters in Europe Designed for a Wide Range of Treatments for Small Peripheral Blood Vessels Including Ones Below The Knee
December 15, 2014 Corporate Government of Ghana Endorses Collaboration to Combat Ebola Epidemic Page Content AABB, Global Blood Fund and Terumo BCT commit resources to Ghanaian Ebola Readiness and Resilience Initiative
December 04, 2014 Corporate Terumo receives CE Mark approval for the line extension on Drug-eluting Stent, Ultimaster® to advance the treatment of coronary artery disease
October 31, 2014 Corporate Terumo Announces its Application for the Manufacture and Sales Approval of its Skeletal Myoblast Sheets - To Aim for the World's First Cardiac Regenerative Therapy (PDF 217.6 KB)
October 23, 2014 Corporate Terumo transforms product portfolio of Hospital and Laboratory Business in Europe (PDF 177.35 KB)
September 23, 2014 Corporate Terumo Cardiovascular Group to Distribute Nonin Medical’s SenSmart™ Model X-100 Universal Oximetry System in U.S. Cardiovascular Hospitals
August 06, 2014 Financial Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 56.35 KB)
May 20, 2014 Corporate Terumo BCT Enters Agreement with Kaneka CorporationMulti-year collaboration agreement for the combined use of therapeutic apheresis and columns for LDL reduction
May 15, 2014 Corporate Terumo® Launches Expanded GLIDEWAY™ Access Sheath Portfolio With A New Product For Minimally Invasive Urologic Procedures New GLIDEWAY™ Ureteral Access Sheath Offers Advanced Features Designed to Minimize Trauma
May 08, 2014 Financial Notice Concerning the Renewal of a Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures) (PDF 129.84 KB)
April 24, 2014 Corporate Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA)
April 02, 2014 Corporate Terumo Expands Sales Collaboration in Japan with Biosensors for Nobori® DES and Extends Licensing Agreement to Sell the Product Overseas
March 25, 2014 Corporate Terumo BCT Becomes Therakos Inc. Distributor in Latin America Multi-year agreement enables Terumo BCT to provide Therakos products in several Latin American countries
March 14, 2014 Corporate Terumo Announces Exclusive Acquisition Right Agreement with French Bioresorbable Scaffold Company, "ART"
February 12, 2014 Corporate Terumo Wins Pharmapack 2014 Award For Nanopass® 34 Pen-Needle In The Category "Quality Of Life"
January 28, 2014 Corporate Nonin Medical Announces U.K. and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart™ Universal Oximetry System
January 28, 2014 Corporate U.S. Food and Drug Administration Clears Granulocyte Collection Procedure on the Spectra Optia Apheresis System Granulocyte, or polymorphonuclear [PMN] cell, collections on the next-generation therapeutic apheresis platform to optimize cellular collections and supplement current protocol offering